推荐产品
描述
anionic
產品線
BioXtra
化驗
~98%
形狀
powder
分子量
244.33 g/mol
技術
HPLC: suitable
雜質
≤0.001% Phosphorus (P)
≤0.1% Insoluble matter
mp
>300 °C (lit.)
溶解度
200 mg, clear, colorless (in 4 mL H2O)
負離子痕跡
chloride (Cl-): ≤0.05%
正離子痕跡
Al: ≤0.0005%
Ca: ≤0.0005%
Cu: ≤0.0005%
Fe: ≤0.0005%
K: ≤0.005%
Mg: ≤0.0005%
NH4+: ≤0.05%
Pb: ≤0.001%
Zn: ≤0.0005%
SMILES 字串
[Na+].CCCCCCCCCCS([O-])(=O)=O
InChI
1S/C10H22O3S.Na/c1-2-3-4-5-6-7-8-9-10-14(11,12)13;/h2-10H2,1H3,(H,11,12,13);/q;+1/p-1
InChI 密鑰
AIMUHNZKNFEZSN-UHFFFAOYSA-M
正在寻找类似产品? 访问 产品对比指南
應用
Sodium 1-decanesulfonate has been used in a study to assess transportation of atrazine and paraquat through nanochannels. It has also been used in a study to investigate the photocycle of bacteriorhodopsin upon chemical modification with surfactants.
HPLC(包括肽和蛋白质)分析的离子缔合试剂。
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
個人防護裝備
dust mask type N95 (US), Eyeshields, Gloves
Photochemistry and photobiology, 86(2), 316-323 (2009-12-17)
The spectroscopic and kinetic studies of the interaction between bacteriorhodopsin in the M-intermediate and several surfactants (cetyl trimethyl ammonium bromide, dodecyl trimethyl ammonium bromide, diethylene glycol mono-n-hexyl ether, ethylene glycol mono-n-hexyl ether, sodium 1-decanesulfonate and sodium 1-heptanesulfonate) have been investigated
Influence of sodium 1-decanesulfonate on the enthalpy of activation of two-step Zn2+ ions electroreduction
Journal of Electroanalytical Chemistry (Lausanne Switzerland), 662, 8-8 (2001)
Study of transportation of atrazine and paraquat through nanochannels
Journal of Membrane Science , 356, 6-6 (2010)
Journal of medicinal chemistry, 52(14), 4338-4344 (2009-06-19)
The hydrophobic pocket within the coiled coil domain of HIV-1 gp41 is considered to be a hot-spot suitable for small molecule intervention of fusion, although so far it has yielded only microM inhibitors. Previous peptide studies have identified specific hydrophobic
Journal of pharmaceutical sciences, 103(7), 2157-2165 (2014-05-16)
The major obstacle to glioblastoma pharmacological therapy is the overcoming of the blood-brain barrier (BBB). In literature, several strategies have been proposed to overcome the BBB: in this experimental work, solid lipid nanoparticles (SLN), prepared according to fatty acid coacervation
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门